Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and development of selective cancer therapies to treat patients across a range of solid tumors with...

32 scientific abstracts reflect ongoing commitment to improving outcomes for people living with epilepsies Data include the use of FINTEPLA® (fenfluramine)1 oral solution in seizures associated...

Grodan, the global leader in innovative stone wool growing media solutions for the professional horticulture industry, in collaboration with F1 SeedTech, the leading breeder of F1 hybrid cannabis...

Initial results from a First-In-Human Ph1 study in relapsed refractory Acute Myeloid Leukemia (AML) patients treated with BL-M11D1, a novel CD33 antibody-drug conjugate (ADC) REDMOND, Wash., Nov....

Remix Therapeutics (Remix), a clinical-stage biotechnology company developing small molecule therapies to modulate RNA processing and address the underlying drivers of disease, today announced...

AIRS Medical, a leader in AI-driven diagnostic imaging solutions, is excited to present its latest innovations at the 2024 Radiological Society of North America (RSNA) conference at McCormick Place in

Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that Douglas E. Onsi, President and Chief Executive...

Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today...

Creality proudly participated in Formnext 2024, continuing its tradition of excellence as a long-standing exhibitor at one of the world's premier trade fairs for additive manufacturing. This year,...

A new study of high school football players found that concussions affect an often-overlooked but important brain signal. The findings are being presented next week at the annual meeting of the...